MedTrace Logo

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

NCT02310698 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 487

Last updated 2025-03-28

No results posted yet for this study

Summary

Breast tumors are often detected on mammography but may be harder to see in women with dense breasts. This is why screening breast ultrasound is sometimes used as another test in women with dense breasts. Ultrasound has been shown to detect additional cancers that are not seen on regular mammography.

Contrast Enhanced Digital Mammography (CEDM) is a FDA approved form of mammography. It is essentially a routine digital mammogram performed after iodine dye (the same that is used with CT scans) is injected into a vein in the arm. Like screening ultrasound, CEDM has been shown to detect breast cancers that are not seen on a regular mammogram. The purpose of this study is to compare whether CEDM or screening breast ultrasound is better at detecting cancer. Both will be done in this study and compared to one another.

Conditions

  • Breast Cancer Screening

Interventions

DEVICE

contrast enhanced digital mammography (CEDM)

DEVICE

whole breast screening ultrasound (WBUS)

Sponsors & Collaborators

Principal Investigators

  • Janice Sung, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-02
Primary Completion
2025-03-26
Completion
2025-03-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02310698 on ClinicalTrials.gov